Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC
NCT04144608
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Advanced Non Small Cell Lung Cancer
Interventions
DRUG:
Toripalimab
Sponsor
Yongchang Zhang